Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Seligson

Showing results (161-170 of 195) with videos related to

Pageof 20
Sort By:
The Annals of Pharmacotherapy|December 16, 2017
Evaluating the Impact of the Addition of Cladribine to Standard Acute Myeloid Leukemia Induction TherapyNathan D Seligson, Athena L V Hobbs, Joanna M Leonard, et al.
The New England Journal of Medicine|July 21, 1983
The clinical importance of a protein-bound fraction of serum bilirubin in patients with hyperbilirubinemiaJ S Weiss, A Gautam, J J Lauff, et al.
Clinical Chemistry|August 1, 1984
Diazo-based assay for total bilirubin in a coated thin film evaluatedJ S Weiss, M W Sundberg, G M Dappen, et al.
Cell Death Discovery|June 23, 2020
Convergence of therapy-induced senescence (TIS) and EMT in multistep carcinogenesis: current opinions and emerging perspectivesMir Mohd Faheem, Nathan D Seligson, Syed Mudabir Ahmad, et al.
The Annals of Pharmacotherapy|May 29, 2025
Revumenib for Relapsed or Refractory Acute Leukemia With a <i>KMT2A</i> TranslocationEmilie J Lynch, Sarah Jane E Faro, Alec M Lindstrom, et al.
Molecular Carcinogenesis|May 3, 2023
CDK4/6 and autophagy inhibitors synergize to suppress the growth of human head and neck squamous cell carcinomasErnest Duah, Nathan D Seligson, Avinash K Persaud, et al.
Clinical Chemistry|August 1, 1984
Estimation of unconjugated, conjugated, and "delta" bilirubin fractions in serum by use of two coated thin filmsM W Sundberg, J J Lauff, J S Weiss, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|July 28, 2025
Opportunities for Pharmacogenomics in Pediatrics: Prescribing Trends of Psychiatric Medications With Pharmacogenomic Implications at a Multistate Pediatric Health SystemMegan L Miller, Nathan D Seligson, Benjamin Q Duong, et al.
Oncotarget|October 18, 2019
Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcomaNathan D Seligson, Colin W Stets, Bryce W Demoret, et al.
Surgical Oncology|August 30, 2024
Molecular markers of proliferation, DNA repair, and immune infiltration defines high-risk subset of resectable retroperitoneal sarcomasNathan D Seligson, Yan W Asmann, Tariq Almerey, et al.
Pageof 20

Showing results (161-170 of 195) with videos related to

Sort By:
Pageof 20
The Annals of Pharmacotherapy|December 16, 2017
Evaluating the Impact of the Addition of Cladribine to Standard Acute Myeloid Leukemia Induction TherapyNathan D Seligson, Athena L V Hobbs, Joanna M Leonard, et al.
The New England Journal of Medicine|July 21, 1983
The clinical importance of a protein-bound fraction of serum bilirubin in patients with hyperbilirubinemiaJ S Weiss, A Gautam, J J Lauff, et al.
Clinical Chemistry|August 1, 1984
Diazo-based assay for total bilirubin in a coated thin film evaluatedJ S Weiss, M W Sundberg, G M Dappen, et al.
Cell Death Discovery|June 23, 2020
Convergence of therapy-induced senescence (TIS) and EMT in multistep carcinogenesis: current opinions and emerging perspectivesMir Mohd Faheem, Nathan D Seligson, Syed Mudabir Ahmad, et al.
The Annals of Pharmacotherapy|May 29, 2025
Revumenib for Relapsed or Refractory Acute Leukemia With a <i>KMT2A</i> TranslocationEmilie J Lynch, Sarah Jane E Faro, Alec M Lindstrom, et al.
Molecular Carcinogenesis|May 3, 2023
CDK4/6 and autophagy inhibitors synergize to suppress the growth of human head and neck squamous cell carcinomasErnest Duah, Nathan D Seligson, Avinash K Persaud, et al.
Clinical Chemistry|August 1, 1984
Estimation of unconjugated, conjugated, and "delta" bilirubin fractions in serum by use of two coated thin filmsM W Sundberg, J J Lauff, J S Weiss, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|July 28, 2025
Opportunities for Pharmacogenomics in Pediatrics: Prescribing Trends of Psychiatric Medications With Pharmacogenomic Implications at a Multistate Pediatric Health SystemMegan L Miller, Nathan D Seligson, Benjamin Q Duong, et al.
Oncotarget|October 18, 2019
Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcomaNathan D Seligson, Colin W Stets, Bryce W Demoret, et al.
Surgical Oncology|August 30, 2024
Molecular markers of proliferation, DNA repair, and immune infiltration defines high-risk subset of resectable retroperitoneal sarcomasNathan D Seligson, Yan W Asmann, Tariq Almerey, et al.
Pageof 20